Intestinal mucosal surfaces harbor a vast complex microbial ecosystem, the microbiome, which is intimately involved in host development and protection. One member of this ecosystem is Enterococcus faecalis (EF), a "pathobiont" that normally lives symbiotically with its host, but also can invade the host and cause systemic disease when intestinal homeostasis is disrupted. It is therefore an ideal model organism that can be used in a complex ecosystem to probe bacterial-host interactions that contribute to enterococcal niche formation in the GI tract. We hypothesize that EF establishes its niche in the GI tract through complex interactions between the bacterium and host. To investigate the host effect on the bacterium and the bacterium effect on the host we will use a novel mouse model for intestinal EF colonization. We will employ recombinase-based in vivo expression technology (RIVET) to investigate the impact of the host intestinal environment on EF (Aim 1). We will then determine the impact of EF colonization and bacteriocin production on host intestinal mucosal gene expression, using microarray technology. We anticipate that we will identify several microbial and host factors that are essential for EF's ability to establish stable colonization of he GI tract. With this knowledge we will begin to carry out specific analyses of both bacterial and host genes to determine their role in the process of EF niche formation in the GI tract. Ultimately, these findings will lead to a greater understanding of the complex bacterial-host interactions that allow persistent intestinal colonization by these multi-antibiotic resistant hospital-acquired bacteria, and offer insight into the interactions that result in enterococcal translocation and host systemic infection.
The gastrointestinal tract is colonized by trillions of bacteria that have an important role in health and disease. One of these bacteria, Enterococcus faecalis, can cause serious illness in hospitalized patients when it spreads from the GI tract, because it is resistant to many antibiotics. The goal of these studies is to understand how bacteria that are normally found in the intestinal tract and the host interact with each other to allow bacterial colonization but prevent infection. Ultimately, by understanding the mechanisms involved in the interaction between Enterococcus faecalis and the GI tract, we will develop new approaches for manipulating this interaction to benefit individual health and prevent disease.
|Ray, Avijit; Basu, Sreemanti; Gharaibeh, Raad Z et al. (2015) Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in Macrophages. J Immunol 195:3071-85|
|Kommineni, Sushma; Bretl, Daniel J; Lam, Vy et al. (2015) Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature 526:719-22|
|Porter, Edith; Valore, Erika V; Anouseyan, Rabin et al. (2015) Detection of antimicrobial (poly)peptides with Acid urea polyacrylamide gel electrophoresis followed by Western immunoblot. Methods Mol Biol 1225:105-15|
|Salzman, Nita H (2014) The role of the microbiome in immune cell development. Ann Allergy Asthma Immunol 113:593-8|